# Vivimed Labs Ltd (VIVIMEDLAB)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹6.44
Day Change: -1.53%
52W High: ₹29.4
52W Low: ₹4.95
Market Cap: ₹54 Cr

## Valuation
P/E: 0
P/B: -1.14
EPS: ₹-4.21
Book Value: ₹0
Dividend Yield: 0%

## Returns
1Y Return: 32.12%

## Profitability
ROE: 0%
ROCE: -41.46%
Debt/Equity: 0
Revenue Growth: -56.3%
Profit Growth: 0%
EBITDA Margin: -10.62%
Operating Margin: -97.25%

## About
Vivimed Labs Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Vivimed Labs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Quarterly Report: Board Meeting Intimation for Audited Results
- Announcement: Corporate Insolvency Resolution Process (CIRP)-Public Announcement
- BSE Filing: Corporate Insolvency Resolution Process (CIRP)-Public Announcement

## Access
Current tier: anonymous
More history: Register free to see 13 more years.

## Data Freshness
Quote Updated: 2026-05-25T12:00:11.977Z
Price History Updated: 2026-05-25T05:37:27.245Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:37:27.245Z
Quant Updated: 2026-05-25T05:37:27.245Z
Sentiment Updated: 2026-05-25T05:37:27.245Z
Financials Status: current
Financials Updated: 2026-05-19T14:31:56.582Z
Financials Last Attempt: 2026-05-19T14:31:56.582Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹116.27 Cr
Operating Profit: ₹-29 Cr (OPM -24.94%)
Net Profit: ₹-31.96 Cr
Tax: ₹0.11 Cr

## Annual P&L History
FY25: Rev ₹116.27Cr | PAT ₹-31.96Cr | OPM -24.94%
FY24: Rev ₹149.07Cr | PAT ₹-45.45Cr | OPM -13.85%
FY23: Rev ₹187.1Cr | PAT ₹-328.54Cr | OPM -109.94%

## Balance Sheet (FY25)
Total Assets: ₹920.83 Cr
Total Liabilities: ₹956 Cr
Borrowings: ₹376.33 Cr
Cash: ₹0.71 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Manohar Rao Varalwar, Whole Time Chairman
- Santosh  Varalwar, MD & Executive Director
- Yugandhar  Kopparthi, Compliance Officer & Company Secretary
- Sandeep  Varalwar B.Pharma, Whole Time Director

---
Source: rupiya.io/stocks/vivimedlab
Disclaimer: For research and education only. Not investment advice.